June 15–18, 2022 | San Francisco, CA
The ISSCR 2022 Annual Meeting brings together stem cell scientists, students, clinicians, and industry leaders from all over the world to exchange exciting new results and ideas in an unique forum. Available both virtually and in person, this year’s meeting will offer more flexibility for all attendees, promising one of the most innovative ISSCR experiences to date.
We are pleased to make our own contributions and present our solutions both in person and virtually. Are you travelling to San Francisco? Come join our Innovation Showcase on June 16 to listen to expert insight "from culture to visualization: eye-opening solutions for pluripotent stem cells", and visit our booth to learn more about our various technologies. If not, no worries, scroll down and discover our wide range of bench-top to bedside solutions for your specific stem cell applications, such as our high-quality media for your pluripotent stem cell (PSC) cultures or the CliniMACS Prodigy® for automated and closed PSC manufacturing.
In the first part of this talk, Sebastian Knöbel, PhD, Senior R&D Manager at Miltenyi Biotec B.V. & Co. KG will present recent product developments for pluripotent stem cell (PSC) culture, expansion, and characterization. He will highlight how manual PSC workflows can benefit from these developments and pave the way for manufacture in a closed system like the CliniMACS Prodigy Adherent Cell Culture process. Moreover, he will introduce the growing MACS® Imaging and Microscopy portfolio at Miltenyi and highlight how it can support stem cell researchers.
In the second part of the talk, Kåre Kryger Vøls, DVM, PhD, Research Scientist at Novo Nordisk A/S, will introduce the importance of innovative microscopy techniques in the stem cell field. He will give a special focus to light sheet fluorescence microscopy (LSFM), a technique that plays a central role in the development of cell therapies at Novo Nordisk. In fact, before transplantation, organoids are characterized by a combination of conventional histology and LSFM in order to describe their cell composition and spatial organization. After transplantation, cell delivery, biodistribution, graft size, and graft survival are evaluated by in vivo imaging and ex vivo LSFM. These readouts are key parameters linked to the efficacy and safety of cellular products.
Speaker: Sebastian Knöbel, PhD
Senior Manager R&D, Miltenyi Biotec B.V. & Co. KG
Sebastian Knöbel, PhD, studied cell biology and genetics and specialized on pluripotent stem cells and derivation of relevant derivatives for regenerative medicine applications. He is Senior Manager in the department of Molecular Technologies and Stem Cell Therapies leading the groups for regenerative medicine and cell culture media development.
Speaker: Kåre Kryger Vøls, DVM, PhD
Research Scientist Cell Imaging and Pharmacology, Novo Nordisk A/S.
Kåre Kryger Vøls, DVM, PhD, is a veterinarian with a specialty in biomedicine and a PhD in in vivo pharmacology. Since 2019, he has been employed as a scientist in cell therapy research at Novo Nordisk, involved primarily in projects about type 1 diabetes and chronic heart failure.